// App-Quantinova.ai

SAT0483 : SAFETY OF INTRAVENOUS IBANDRONIC ACID IN CHRONIC KIDNEY DISEASE: A REAL WORLD EXPERIENCE

Researchers

Presenter

  • J. Southern

Principal Investigators

  • M. Chakravorty

  • L. H. Lee

Medical Centers

  • Royal Derby Hospital, Derby, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Musculoskeletal

Disease

  • Chronic kidney disease

  • Acute renal failure

  • Renal disease

  • Osteoporosis

Biomarkers

  • Creatinine

Drug/Treatment

  • Ibandronic acid

  • Ergocalciferol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved